2024-05-19
2024-05-19
November 21, 2024
Summary | |
---|---|
Cancer Type | Melanoma |
Grade | NA |
Stage | NA |
Ethnicity | Western |
Gender | F |
Age | 43 |
Pathology Diagnosis | Malignant melanoma |
Biopsy Site | Right Axillary LN |
Treatment History | F |
Pathology QC | Malignant melanoma (P2), IHC results: MeloN/A (1-2+), S100 (3+), HMB45 (3+), T311 (2+), CK (1+), Vimentin (3+) (P2). |
Special Features | N/A |
Mouse Strain | NOD SCID |
TMA | TMA-HP-ME-211 |
Viral Status in PDX | HPV16-, HPV18-, HIV-, HCV-, HBV-, EBV- |
Available In | CB_CN |
RNA Seq | P0 |
Exome Seq | N/A |
Sq # | 12009 |
Source | CBSD |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2024 Crown Bioscience. All Rights Reserved.
© 2024 Crown Bioscience. All Rights Reserved. Privacy Policy